Interpace Biosciences (IDXG) Reports Q1 EPS of $0.03
Tweet
Share
E-mailGet Alerts IDXG Hot Sheet
Join SI Premium – FREE
Interpace Biosciences (OTC: IDXG) reported Q1 EPS of $0.03. Revenue for the quarter came in at $9.03 million.
For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- HSBC Upgrades Sembcorp Industries (SCI:SP) to Buy
- Bernstein SocGen Group Upgrades Wayfair (W) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
